The 2011 Leading Pharmaceutical Companies Collaborative Arrangements

Complete report $1,850.  Individual company assessments $250.

For each company, the report analyzes:

• Major joint venture, distribution, OEM, and licensing partners, both industrial and academic.
• Terms of collaborative agreements and specific products involved.

         -   Abbott
         -   AstraZeneca
         -   Eli Lilly
         -   GlaxoSmithKline
         -   Johnson & Johnson
         -   Merck
         -   Novartis
         -   Pfizer
         -   Roche
         -   Sanofi-Aventis 

Contains 200 pages